Stay updated on Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial
Sign up to get notified when there's something new on the Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial page.

Latest updates to the Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice appears above the study record announcing NIH website changes and explaining that “Super Intelligence” may be used in place of “Artificial Intelligence” during the transition.SummaryDifference0.7%

- Check28 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, with the study record content unchanged.SummaryDifference0.1%

- Check35 days agoChange DetectedThe website footer’s revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry (v3.7.0) was added to the study history. This indicates the record was updated and resubmitted.SummaryDifference0.1%

- Check77 days agoChange DetectedThis revision removes the footer/navigation block that appeared in earlier versions, resulting in a shorter bottom section of the page and a simplified view of the study record history.SummaryDifference14%

Stay in the know with updates to Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial page.